PETALING JAYA: Pathology & Clinical Laboratory (M) Sdn Bhd, a South-East Asian medical testing company, is considering selling its business in Malaysia which could fetch about US$200mil (RM949mil) in a transaction, according to people with knowledge of the matter.
Pathlab, as the company is known, is working with an adviser on the potential divestment, the people said.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
